Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) Profit Margin

Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) (SRNGU) currently reports a profit margin of -468.76% as of September 2026. That compares with -188.0% in the prior-year period — down 149.3% year over year. That is below the Healthcare sector average of 19.13%. Use the charts on this page to explore Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s profit margin history and peer comparisons.

Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s profit margin decreased from -188.0% to -468.76% — a 149.3% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s profit margin of -468.76% is lower than the Healthcare sector average of 19.13%. That is roughly 2550.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s current -468.76% should be judged against Healthcare norms (sector average: 19.13%) and against SRNGU's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -468.76%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 19.13%. From there, open related valuation or income-statement pages for Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War), and consider following SRNGU for alerts when major investors trade the stock.